🔎 Trials Near Me

Domov › Rakovina (všetky typy) › South Carolina

Klinické štúdie Rakovina (všetky typy) v štáte South Carolina

29 štúdií pre Rakovina (všetky typy) hľadá účastníkov v zariadeniach v štáte South Carolina.

Mestá v štáte South Carolina

Oficiálny text štúdie (anglicky)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Medical University of South Carolina, Florence
  • Medical University of South Carolina Health Lancaster Medical Center, Lancaster
Prebieha náborFáza 3
Vek 18 až 100 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05920356

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  • Prisma Health, Greenville
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06150157

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

  • SC Cancer Specialists at St. Joseph's/Candler Bluffton, Bluffton
  • St. Joseph's/Candler Smith, Bluffton
  • Summit Cancer Care at St. Josph's/Candler Bluffton, Bluffton
  • a 1 ďalších
Prebieha náborFáza 2
Vek 12 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT02693535

Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)

  • Medical University of South Carolina Hollings Cancer Center, Charleston
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT07227610

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

  • Hematology and Oncology Associates of SC, LLC, Greenville
Prebieha náborFáza 2/3
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT03435796

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • MUSC Health University Medical Center, Charleston
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT04996875

Evaluating the Communication Between Patients and Providers in Cancer Clinics

  • Medical University of South Carolina, Charleston
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06985953

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • South Carolina Cancer Specialists PC, Hilton Head Island
  • The Radiation Oncology Center-Hilton Head/Bluffton, Hilton Head Island
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06756607

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Medical University of South Carolina, Charleston
  • Prisma Health Cancer Institute, Greenville
  • Lexington Medical Center, West Columbia
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT06119581

Project: Every Child for Younger Patients With Cancer

  • Medical University of South Carolina, Charleston
  • Prisma Health Richland Hospital, Columbia
  • BI-LO Charities Children's Cancer Center, Greenville
  • a 2 ďalších
Prebieha náborObservačná štúdia
Do veku 25 · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT02402244

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

  • START - Carolinas, Myrtle Beach
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT07480356

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  • Gibbs Cancer Center-Gaffney, Gaffney
  • Gibbs Cancer Center-Pelham, Greer
  • Spartanburg Medical Center, Spartanburg
  • a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT06580314

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

  • Prisma Health Cancer Institute, Greenville
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 7. 2026 · NCT06657144

Optimizing Care for Cancer Survivors With Depression: Project 3

  • Medical University of South Carolina, Charleston
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 7. 2026 · NCT06930729

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 9. 7. 2026 · NCT07103018

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

  • Medical University of South Carolina Hollings Cancer Center, Charleston
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 7. 2026 · NCT07149207

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
  • Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC, Columbia
Prebieha nábor
Vek 18 až 75 · Všetky pohlavia · Aktualizované 17. 6. 2026 · NCT05486572

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

  • GSK Investigational Site, Myrtle Beach
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT06551142

IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)

  • Medical University of South Carolina, Charleston
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT06582784

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

  • Prisma Health-Upstate, Greenville
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 4. 2026 · NCT06487624

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

  • Medical University of South Carolina (MUSC), Charleston
  • PRISMA Health, Institute for Translational Oncology, Greenville
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 3. 2026 · NCT06014658

Prevent Cancer- Greenville

  • Prisma Health-Upstate, Greenville
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 2. 2026 · NCT04947098

GEMINI-NSCLC: NSCLC Biomarker Study

  • The Medical University of South Carolina, Charleston
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 2. 2026 · NCT05236114

Beat Childhood Cancer Specimen Banking and Data Registry

  • Medical University of South Carolina, Charleston
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 3. 2. 2026 · NCT04715178

Reducing Metabolic Dysregulation in Dyads

  • University of South Carolina, Columbia
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 9 až 55 · Všetky pohlavia · Aktualizované 29. 1. 2026 · NCT06117241

Caris Biorepository Research Protocol

  • Clinical Biotechnology Research Institute at RSFH, Charleston
  • Spartanburg Regional Health Services, Spartanburg
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 1. 2026 · NCT01499394

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Greenville
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Medical University of South Carolina, Charleston
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 11. 2024 · NCT03860883

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.